NCT07557459 Access to Probing and Peri-implant Diseases
| NCT ID | NCT07557459 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Arrow Development |
| Condition | Peri-implantitis |
| Study Type | OBSERVATIONAL |
| Enrollment | 281 participants |
| Start Date | 2026-09-01 |
| Primary Completion | 2027-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 281 participants in total. It began in 2026-09-01 with a primary completion date of 2027-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This multicenter cross-sectional study aims to evaluate the association between access to peri-implant probing and radiographic peri-implant bone loss. Although probing is the primary diagnostic tool for peri-implant diseases, prosthetic design may limit access, potentially affecting diagnosis and disease progression. The study will include patients with dental implants in function for at least three years and will assess clinical, radiographic, and prosthetic variables.
Eligibility Criteria
Inclusion Criteria: * Age ≥18 years * Dental implants loaded for at least 3 years * Implant-supported restorations (single, partial fixed, or full-arch) * First visit to the clinic (maintenance, review, or treatment) * Signed informed consent * Availability of clinical and radiographic records Exclusion Criteria: * Exposure of the intraosseous portion of the implant * Evident prosthetic misfit * Inability to provide informed consent * Lack of cooperation for clinical examination
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07557459 clinical trial?
This trial is open to participants of all sexes, studying Peri-implantitis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07557459 currently recruiting?
Yes, NCT07557459 is actively recruiting participants. Contact the research team at arrow@archealth.eu for enrollment information.
Where is the NCT07557459 trial being conducted?
This trial is being conducted at A Coruña, Spain, Guadalajara, Spain, Madrid, Spain, Madrid, Spain and 5 additional locations.
Who is sponsoring the NCT07557459 clinical trial?
NCT07557459 is sponsored by Arrow Development. The trial plans to enroll 281 participants.